Last updated: 5 September 2024 at 9:45am EST

Richard Eskew Net Worth




The estimated Net Worth of Richard Eskew is at least $214 millier dollars as of 3 September 2024. Mr Eskew owns over 1,146 units of Accolade stock worth over $200,290 and over the last 2 years he sold ACCD stock worth over $13,936.

Mr Eskew ACCD stock SEC Form 4 insiders trading

Mr has made over 26 trades of the Accolade stock since 2023, according to the Form 4 filled with the SEC. Most recently he exercised 1,146 units of ACCD stock worth $4,481 on 3 September 2024.

The largest trade he's ever made was exercising 10,725 units of Accolade stock on 11 June 2024 worth over $41,935. On average, Mr trades about 1,441 units every 17 days since 2023. As of 3 September 2024 he still owns at least 51,225 units of Accolade stock.

You can see the complete history of Mr Eskew stock trades at the bottom of the page.





Mr. Richard Eskew biography

Richard Eskew is the Exec. VP, Gen. Counsel & Chief Privacy Officer at Accolade.



What's Mr Eskew's mailing address?

Richard's mailing address filed with the SEC is C/O ACCOLADE, INC., 1201 THIRD AVENUE, SUITE 1700, SEATTLE, WA, 98101.

Insiders trading at Accolade

Over the last 4 years, insiders at Accolade have traded over $9,006,680 worth of Accolade stock and bought 74 units worth $743 . The most active insiders traders include Edgar Jr Bronfman, Jeffrey D Jordan et Dawn G Lepore. On average, Accolade executives and independent directors trade stock every 5 days with the average trade being worth of $18,928. The most recent stock trade was executed by Rajeev Singh on 3 September 2024, trading 3,786 units of ACCD stock currently worth $14,803.



What does Accolade do?

Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.



What does Accolade's logo look like?

Accolade, Inc. logo

Complete history of Mr Eskew stock trades at Accolade

Date
#
Société
Initié
Trans.
Transaction
Actions Prix par action Prix ​​total Actions après Source
3 Sep 2024 Richard Eskew
EVP General Counsel
Exercice d'option 1,146 $4.41 $5,054
3 Sep 2024
51,225
1 Aug 2024 Richard Eskew
EVP General Counsel
Exercice d'option 1,145 $3.88 $4,443
1 Aug 2024
50,424
1 Jul 2024 Richard Eskew
EVP General Counsel
Exercice d'option 1,146 $3.54 $4,057
1 Jul 2024
49,624
11 Jun 2024 Richard Eskew
EVP General Counsel
Exercice d'option 10,725 $6.61 $70,892
11 Jun 2024
51,707
1 May 2024 Richard Eskew
EVP General Counsel
Exercice d'option 1,638 $7.36 $12,056
1 May 2024
40,639
1 Apr 2024 Richard Eskew
EVP General Counsel
Exercice d'option 1,639 $10.13 $16,603
1 Apr 2024
39,588
1 Mar 2024 Richard Eskew
EVP General Counsel
Exercice d'option 1,639 $9.96 $16,324
1 Mar 2024
38,434
20 Feb 2024 Richard Eskew
EVP General Counsel
Vente 400 $12.09 $4,836
20 Feb 2024
36,795
1 Feb 2024 Richard Eskew
EVP General Counsel
Exercice d'option 1,638 $11.73 $19,214
1 Feb 2024
37,757
19 Jan 2024 Richard Eskew
EVP General Counsel
Vente 400 $11.99 $4,796
19 Jan 2024
36,119
2 Jan 2024 Richard Eskew
EVP General Counsel
Exercice d'option 1,639 $12.24 $20,061
2 Jan 2024
37,109
19 Dec 2023 Richard Eskew
EVP General Counsel
Vente 400 $10.76 $4,304
19 Dec 2023
35,470
1 Dec 2023 Richard Eskew
EVP General Counsel
Exercice d'option 1,639 $8.69 $14,243
1 Dec 2023
35,088
1 Nov 2023 Richard Eskew
EVP General Counsel
Exercice d'option 1,638 $6.55 $10,729
1 Nov 2023
33,138
2 Oct 2023 Richard Eskew
EVP General Counsel
Exercice d'option 1,639 $10.47 $17,160
2 Oct 2023
33,235
1 Sep 2023 Richard Eskew
EVP General Counsel
Exercice d'option 1,639 $14.03 $22,995
1 Sep 2023
32,071
1 Aug 2023 Richard Eskew
EVP General Counsel
Exercice d'option 1,639 $14.98 $24,552
1 Aug 2023
30,921
3 Jul 2023 Richard Eskew
EVP General Counsel
Exercice d'option 1,638 $13.37 $21,900
3 Jul 2023
28,547
1 Jun 2023 Richard Eskew
EVP General Counsel
Exercice d'option 4,139 $12.19 $50,454
1 Jun 2023
25,557
25 May 2023 Richard Eskew
EVP General Counsel
Exercice d'option 1,273 $11.39 $14,499
25 May 2023
25,514
25 May 2023 Richard Eskew
EVP General Counsel
Exercice d'option 1,272 $11.39 $14,488
25 May 2023
24,592
24 May 2023 Richard Eskew
EVP General Counsel
Exercice d'option 1,273 $11.91 $15,161
24 May 2023
24,593
23 May 2023 Richard Eskew
EVP General Counsel
Exercice d'option 1,272 $11.08 $14,094
23 May 2023
21,996
19 May 2023 Richard Eskew
EVP General Counsel
Exercice d'option 1,272 $10.69 $13,598
19 May 2023
21,085
1 May 2023 Richard Eskew
EVP General Counsel
Exercice d'option 389 $13.02 $5,065
1 May 2023
19,925
3 Apr 2023 Richard Eskew
EVP General Counsel
Exercice d'option 388 $14.24 $5,525
3 Apr 2023
19,669


Accolade executives and stock owners

Accolade executives and other stock owners filed with the SEC include: